Patients with CPT1A deficiency often experience multiple morbidities, including hepatic encephalopathy, hypoglycemia, and hyperammonemia (Tan et al., 2011; Raud et al., 2018a). This evidence concerns the gene CPT1A and hyperinsulinemic hypoglycemia, familial, 4.